Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies
-
By
-
Pupu Li
-
Xia Xue
-
Zisen Zhang
-
June 11, 2026
-
Objective:
Expand to include the significance of CAR T-cell therapy in improving patient outcomes in B-cell malignancies.
Key Findings:
- Incorporate specific statistics or data from clinical trials to support the findings.
Interpretation:
Elaborate on the implications of understanding resistance mechanisms for future research directions.
Limitations:
- Provide more detail on the implications of not addressing the challenges of applying CAR T-cell therapy to solid tumors.
Conclusion:
Emphasize the urgency of developing strategies to overcome resistance mechanisms.
